Publication Name	World Journal of Gastroenterology
Manuscript ID	63464
Country	Taiwan

Received	2021-01-28 14:56
Peer-Review Started	2021-01-28 15:19
To Make the First Decision
Return for Revision	2021-05-02 02:11
Revised	2021-05-23 03:29
Second Decision	2021-08-02 02:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-02 06:32
Articles in Press	2021-08-02 06:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-08-16 04:07
Publish the Manuscript Online	2021-08-18 08:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Screening and prevention of hepatitis C virus reactivation during chemotherapy
Manuscript Source	Invited Manuscript
All Author List	Yuan-Rung Li, Tsung-Hui Hu, Wen-Chi Chen, Ping-I Hsu and Hui-Chun Chen
ORCID	Author(s) ORCID Number Yuan-Rung Li http://orcid.org/0000-0002-5041-7731 Tsung-Hui Hu http://orcid.org/0000-0002-9172-1967 Wen-Chi Chen http://orcid.org/0000-0002-7572-4201 Ping-I Hsu http://orcid.org/0000-0003-3905-4674 Hui-Chun Chen http://orcid.org/0000-0002-7843-0882
Funding Agency and Grant Number
Corresponding Author	Ping-I Hsu, PhD, Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, 386 Ta Chung 1st Road, Kaohsiung 813, Taiwan. williamhsup@yahoo.com.tw
Key Words	Hepatitis C virus; Chemotherapy; Screening; Reactivation; Hepatitis flare
Core Tip	Hepatitis C virus (HCV) reactivation occurs in approximately one-fourth of HCV-infected cancer patients receiving chemotherapy. An HCV-related hepatitis flare during chemotherapy may lead to the discontinuation of potentially life-saving chemotherapy. Currently, universal HCV screening is recommended in hematological malignancy patients before chemotherapy, but there is no evidence-based guideline for other cancer patients. direct-acting antivirals treatment can cure HCV infection and prevent HCV reactivation during chemotherapy.
Publish Date	2021-08-18 08:08
Citation	Li YR, Hu TH, Chen WC, Hsu PI, Chen HC. Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol 2021; 27(31): 5181-5188
URL	https://www.wjgnet.com/1007-9327/full/v27/i31/5181.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i31.5181

Full Article (PDF)	WJG-27-5181.pdf
Full Article (Word)	WJG-27-5181.docx
Manuscript File	63464_Auto_Edited-JPY.docx
Answering Reviewers	63464-Answering reviewers.pdf
Audio Core Tip	63464-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63464-Conflict-of-interest statement.pdf
Copyright License Agreement	63464-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63464-Language certificate.pdf
Peer-review Report	63464-Peer-review(s).pdf
Scientific Misconduct Check	63464-Scientific misconduct check.pdf
Scientific Editor Work List	63464-Scientific editor work list.pdf
CrossCheck Report	63464-CrossCheck report.pdf